Perspectives of Healthcare Professionals on the Management and Treatment of Advanced Ovarian Cancer in the UK: Results From the KNOW-OC Survey

PARP-inhibitors in epithelial ovarian cancer: Actual positioning and future expectations

(2021) Hélène Vanacker et al.   CANCER TREATMENT REVIEWS

A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer (Review)

(2021) Luca Falzone et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer

(2021) Philipp Harter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Targeting DNA Repair in Ovarian Cancer Treatment Resistance

(2020) M.W. Wong-Brown et al.   CLINICAL ONCOLOGY

ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†

(2019) N Colombo et al.   ANNALS OF ONCOLOGY

When should Surgery be used for Recurrent Ovarian Carcinoma?

(2018) M. Bommert et al.   CLINICAL ONCOLOGY

Multidisciplinary Team Meetings in Cancer Care: An Idea Whose Time has Gone?

(2015) A.J. Munro   CLINICAL ONCOLOGY